Hydrogen sulfide in renal physiology, disease and transplantation - The smell of renal protection

被引:69
作者
Koning, Anne M. [1 ,2 ]
Frenay, Anne-Roos S. [1 ]
Leuvenink, Henri G. D. [2 ]
van Goor, Harry [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2015年 / 46卷
关键词
Kidney disease; Ischemia-reperfusion; H2S; CSE; CBS; 3MST; CYSTATHIONINE-BETA-SYNTHASE; ISCHEMIA-REPERFUSION INJURY; CHRONIC KIDNEY-DISEASE; GAMMA-LYASE; SODIUM THIOSULFATE; MERCAPTOPYRUVATE SULFURTRANSFERASE; ISCHEMIA/REPERFUSION INJURY; (H2S)-PRODUCING ENZYMES; MITOCHONDRIAL DYNAMICS; SUSPENDED ANIMATION;
D O I
10.1016/j.niox.2015.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen sulfide (H2S), the third gasotransmitter, next to nitric oxide and carbon monoxide, is a key mediator in physiology and disease. It is involved in homeostatic functions, such as blood pressure control, electrolyte balance and apoptosis, and regulates pathological mechanisms, including oxidative stress and inflammation. Besides, it is believed to serve as an oxygen sensor under ischemic conditions. The kidney plays a decisive role in many of these processes, indicating an interplay between H2S and renal (patho)physiology. In this review we focus on the (protective) functions of H2S in the kidney. We first discuss endogenous renal H2S production and signaling and elaborate on its regulatory functions in renal physiology. Next, we present data on the role of aberrant H2S levels in the onset and progression of renal disease and suggest the use of H2S metabolites as biomarkers. Finally, we describe that exogenous H2S can protect the kidney against various forms of injury and conclude that modulation of renal H2S levels holds promise for renal patients in the future. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:37 / 49
页数:13
相关论文
共 146 条
[1]  
Ahmad F.U., 2014, REN FAIL, V36, P1
[2]   Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? [J].
Ali, M. Y. ;
Ping, C. Y. ;
Mok, Y-Y P. ;
Ling, L. ;
Whiteman, M. ;
Bhatia, M. ;
Moore, P. K. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (06) :625-634
[3]   Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease [J].
Aminzadeh, Mohammad A. ;
Vaziri, Nosratola D. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) :498-504
[4]  
[Anonymous], BR J PHARM
[5]  
[Anonymous], UPTODATE
[6]  
[Anonymous], UPTODATE
[7]   Hydrogen Sulfide Donor NaHS Reduces Organ Injury in a Rat Model of Pneumococcal Pneumosepsis, Associated with Improved Bio-Energetic Status [J].
Aslami, Hamid ;
Pulskens, Wilco P. ;
Kuipers, Maria T. ;
Bos, Aafkeline P. ;
van Kuilenburg, Andre B. P. ;
Wanders, Ronald J. A. ;
Roelofsen, Jeroen ;
Roelofs, Joris J. T. H. ;
Kerindongo, Raphaela P. ;
Beurskens, Charlotte J. P. ;
Schultz, Marcus J. ;
Kulik, Wim ;
Weber, Nina C. ;
Juffermans, Nicole P. .
PLOS ONE, 2013, 8 (05)
[8]   A short course of infusion of a hydrogen sulfide-donor attenuates endotoxemia induced organ injury via stimulation of anti-inflammatory pathways, with no additional protection from prolonged infusion [J].
Aslami, Hamid ;
Beurskens, Charlotte J. P. ;
de Beer, Friso M. ;
Kuipers, Maria T. ;
Roelofs, Joris J. T. H. ;
Hegeman, Maria A. ;
Van der Sluijs, Koen F. ;
Schultz, Marcus J. ;
Juffermans, Nicole P. .
CYTOKINE, 2013, 61 (02) :614-621
[9]   Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury [J].
Aslami, Hamid ;
Heinen, Andre ;
Roelofs, Joris J. T. H. ;
Zuurbier, Coert J. ;
Schultz, Marcus J. ;
Juffermans, Nicole P. .
INTENSIVE CARE MEDICINE, 2010, 36 (11) :1946-1952
[10]   Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation [J].
Baskar, Rajamanickam ;
Sparatore, Anna ;
Del Soldato, Piero ;
Moore, Philip Keith .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 594 (1-3) :1-8